American Society of Hirudotherapy

Reverse Sural Flap Venous Congestion Successfully Managed With Enoxaparin in a Male Patient With a Traumatic Foot Crush Injury: A Case Report

Case report published in Cureus (2026)

Last Updated: November 1, 2026ASH Editorial · based on the books
Research article — evidence review: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.Article reference: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.
Evidence: Case reportClinical LiteratureVelasco-Bustamante J et al. · Cureus, 2026

Abstract

The reverse sural flap is a commonly used surgical option for soft-tissue defects of the distal leg, ankle, and heel in hospitals where microsurgical capabilities are limited. However, one of its most frequent complications is venous congestion, which can lead to partial or total flap necrosis if not promptly addressed. We present the case of a patient with a traumatic crush injury of the right ankle, reconstructed with a reverse-flow sural flap that subsequently developed venous congestion in the immediate postoperative period (<12 hours). A local subcutaneous enoxaparin protocol (low-molecular-weight heparin) was implemented as a salvage strategy. This intervention successfully reversed the clinical signs of venous congestion and preserved approximately 80% of the flap's viability. This report discusses the underlying pathophysiology, the applied protocol, previous evidence, and the clinical implications of this approach.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsJournal Article

Summary

A reverse sural flap used for a traumatic ankle crush injury developed venous congestion less than 12 hours after surgery; local subcutaneous enoxaparin reversed the congestion and preserved about 80% of the flap.

Context

This case report examined the management of acute venous congestion in a reverse-flow sural flap used to reconstruct a traumatic ankle crush injury, employing a local subcutaneous enoxaparin (low-molecular-weight heparin) protocol as a salvage intervention that reversed clinical congestion and preserved approximately 80% of the flap. Venous congestion of surgically reconstructed flaps is one of the most established indications for medicinal leech therapy, where leech-mediated venous drainage and salivary anticoagulants serve a similar goal of relieving congestion and preserving tissue viability; consequently, studies of alternative pharmacologic salvage strategies are of comparative interest to the field. However, this is a single case report involving no leeches, no comparative arm, and no evaluation of hirudotherapy itself.

Citation

Reference (Vancouver style)

Velasco-Bustamante J, Velasco-Bustamante D, Bravo-Romero C, Nacimba-Aman C, Peñafiel-Pallares WS. Reverse Sural Flap Venous Congestion Successfully Managed With Enoxaparin in a Male Patient With a Traumatic Foot Crush Injury: A Case Report. Cureus. 2026;18(1):e101926. doi:10.7759/cureus.101926. PMID: 41728432

Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.

Added to ASH library: March 18, 2026 · Site last updated: November 1, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.